People: Aegerion Pharmaceuticals Inc (AEGR.O)
6 Dec 2013
Mr. Paul G. Thomas has been appointed as an Independent Director of Aegerion Pharmaceuticals, Inc., since August 1, 2011. Mr. Thomas is also the chairman of the Audit Committee of the Board of Directors. Mr. Thomas is the founder, and since September 2009 has served as Chief Executive Officer, of Roka Bioscience, Inc., a privately held company principally engaged in the development and commercialization of molecular assays for biopharmaceutical processing, food safety and other industrial testing applications. From October 1998 until August 2008, Mr. Thomas served as Chairman, Chief Executive Officer and President of LifeCell Corporation, a publicly traded company that developed and marketed innovative tissue repair products for use in reconstructive, orthopedic and urogynecologic surgical procedures. LifeCell was acquired in 2008 by Kinetic Concepts, Inc. Prior to joining LifeCell, Mr. Thomas was President and Chief Operating Officer of the Pharmaceutical Products Division of Ohmeda Inc. (now Baxter PPD). Mr. Thomas is also a member of the Board of Directors of AbioMed, Inc., a provider of medical devices that provide circulatory support to acute heart failure patients across the continuum of care in heart recovery. Mr. Thomas received his M.B.A. degree with an emphasis in Marketing and Finance from Columbia University Graduate School of Business, and completed his postgraduate studies in Chemistry at the University of Georgia Graduate School of Arts and Science. He received his B.S. degree in Chemistry from St. Michael’s College in Vermont.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|